GLP-1 receptor agonists that are not substrates of DPP-4 and DPP-4 inhibitors are approved for the treatment of type 2 diabetes
One A 2021 review of research suggests that a combination of protein and calcium may help trigger increased GLP-1 secretion
Signs and symptoms of low blood sugar may include dizziness or light-headedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, or feeling jittery kidney problems (kidney failure)
Bring information about your current health status, any medications you take, and your specific goals
The 503A patient-specific pathway remains legally intact
The opportunity: eating less becomes much easier